Malignant ascites occurs most often in patients with high-grade serous papillary ovarian cancer at initial diagnosis: a retrospective analysis of 191 women treated at Bayreuth Hospital, 2006–2015
- 26 Downloads
Malignant ascites often develops in patients with ovarian cancer, but there is a lack of more detailed characterization of the different histological subtypes.
Ascites specimens from patients with ovarian cancer who were treated at Bayreuth Hospital from 2006 to 2015, with follow-up until December 2016, were reevaluated retrospectively.
A total of 191 women (mean age 64 years, range 48–79) were included, of whom 180 (94.2%) had carcinoma, three (1.6%) had malignant mixed müllerian tumors (MMMTs), four (2.1%) had sex cord–stromal tumors (SCSTs), three (1.6%) had germ cell tumors (GCTs), and one (0.5%) had a sarcoma. The carcinoma group comprised 134 (70.1%) patients with high-grade serous papillary ovarian cancer, 17 (8.9%) with low-grade serous papillary ovarian cancer, 10 (5.3%) with mucinous carcinomas, nine (4.7%) with endometrioid carcinomas, six (3.1%) with clear cell carcinomas, and four (2.1%) with neuroendocrine tumors. The latter group consisted of two patients with mixed neuroendocrine–nonneuroendocrine tumors (MiNENs), one with only a small cell carcinoma (SCCO), and one with a mucinous carcinoid. The noncarcinomatous group of eight patients (4.2%) included three (1.6%) with Sertoli–Leydig cell tumor and mature cystic teratoma (MCT), one (0.5%) with a granulosa cell tumor, and one with a leiomyosarcoma. A statistically significant difference in the proportion of patients with malignant ascites was observed, at 17.7% (3/17) in those with low-grade serous papillary ovarian cancer and 91.8% (123/134) in those with high-grade serous papillary ovarian carcinomas. In both patients with MiNEN, the glandular tumor cell component was found in the ascites. Tumor cells were found in the ascitic fluid in 50% (5/10) of patients with mucinous ovarian carcinomas, 16.7% (1/6) of those with clear cell carcinomas, and 33.3% (1/3) of those with MMMTs. The two patients (2/3; 66.7%) with neoplastic squamous cell components in MCT and the only patient with a granulosa cell tumor in the SCST group (1/4; 25%) had malignant cell populations in the ascites, whereas patients with endometrioid cell carcinoma and leiomyosarcoma lacked tumor cells in the ascites. The malignant ascites was detected at the initial diagnosis in all 138 (100%) patients with ovarian neoplasms.
High-grade serous papillary ovarian cancer was the main histological subtype most frequently found in ascites fluid in this series. The significant difference (P < 0.00001) in the malignancy rate in comparison with low-grade serous papillary carcinoma confirms the histological distinction between the two entities. Initial evidence of ovarian cancer in ascites fluid allows correct primary diagnosis in cytology specimens and is important for staging and prognosis.
KeywordsMalignant ascites Ovarian tumors Histological subtypes
The contribution of A. Ozalinskaite to this publication was performed in partial fulfillment of the requirements for obtaining the degree of Doctor of Medicine. Parts of the study published here have been used for her doctoral thesis at the Medical Faculty of the Friedrich-Alexander University Erlangen-Nuremberg.
JK project development, data collection, data analysis, manuscript writing; CLS data collection, data analysis; BM data collection, manuscript writing; WS data analysis, manuscript editing; AO data collection; JL project development, manuscript editing; AA project development, manuscript editing; MV project development, manuscript editing.
Compliance with ethical standards
Conflict of interest
All authors declare that there are no conflicts of interest.
- 1.Robert Koch Institut. Zentrum für Krebsregisterdaten (2017) Eierstockkrebs (Ovarialkarzinom). https://www.krebsdaten.de/Krebs/DE/Content/Krebsarten/Ovarialkrebs/ovarialkrebs.html. Accessed 16 Mar 2018
- 6.Kurman RJ, International Agency for Research on Cancer, World Health Organization (2014) WHO classification of tumours of female reproductive organs, 4th edn. International Agency for Research on Cancer, LyonGoogle Scholar
- 11.Krugmann J, Melcher B, Deuerling J, Mühldorfer S, Vieth M (2017) Klinisch-zytologische Korrelation der Aszitesdiagnostik bei gastrointestinalen Erkrankungen am Klinikum Bayreuth—eine retrospektive Untersuchung an 256 Patienten. Verdauungskrankheiten 35(3):129–139. https://doi.org/10.5414/VDX0950 CrossRefGoogle Scholar
- 21.Ikeda K, Tate G, Suzuki T, Mitsuya T (2005) Effusion cytodiagnosis of carcinosarcoma derived from the female genital tract: immunohistochemical features of MMP-7 and Ki-67 and immunofluorescence double staining analyses of eight cases. Gynecol Oncol 97(2):323–329. https://doi.org/10.1016/j.ygyno.2004.12.024 (PMID:15863125) CrossRefPubMedGoogle Scholar
- 25.Damiani D, Suciu V, Andreiuolo F, Calderaro J, Vielh P (2015) Young investigator challenge: cytomorphologic analysis of cerebrospinal fluid in 70 pediatric patients with medulloblastoma and review of the literature focusing on novel diagnostic and prognostic tests. Cancer Cytopathol 123(11):644–649. https://doi.org/10.1002/cncy.21633 (PMID:26769585) CrossRefPubMedGoogle Scholar
- 26.Harbhajanka A, Bitterman P, Reddy VB, Park JW, Gattuso P (2016) Cytomorphology and clinicopathologic correlation of the recurrent and metastatic adult granulosa cell tumor of the ovary: a retrospective review. Diagn Cytopathol 44(12):1058–1063. https://doi.org/10.1002/dc.23535 (PMID:27493080) CrossRefPubMedGoogle Scholar
- 27.Social Science Statistics (2018) Chi square test calculator. http://www.socscistatistics.com/tests/chisquare2/Default2.aspx. Accessed 16 Mar 2018
- 30.Sedlaczek P, Frydecka I, Gabryś M, Van Dalen A, Einarsson R, Harłozińska A (2002) Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma. Cancer 95(9):1886–1893. https://doi.org/10.1002/cncr.10917 (PMID:12404282) CrossRefPubMedGoogle Scholar
- 33.Heintz APM, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, Ngan HYS, Pecorelli S, Beller U (2006) Carcinoma of the ovary. FIGO 26th Annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 95(Suppl 1):S161–S192. https://doi.org/10.1016/S0020-7292(06)60033-7 (PMID:17161157) CrossRefPubMedGoogle Scholar
- 38.McCluggage WG, Witkowski L, Clarke BA, Foulkes WD (2017) Clinical, morphological and immunohistochemical evidence that small-cell carcinoma of the ovary of hypercalcaemic type (SCCOHT) may be a primitive germ-cell neoplasm. Histopathology 70(7):1147–1154. https://doi.org/10.1111/his.13177 (PMID:28130795) CrossRefPubMedGoogle Scholar
- 39.Witkowski L, Donini N, Byler-Dann R, Knost JA, Albrecht S, Berchuk A, McCluggage WG, Hasselblatt M, Foulkes WD (2017) The hereditary nature of small cell carcinoma of the ovary, hypercalcemic type: two new familial cases. Fam Cancer 16(3):395–399. https://doi.org/10.1007/s10689-016-9957-6 (PMID:27866340) CrossRefPubMedGoogle Scholar
- 42.Tabrizi AD, Kalloger SE, Köbel M, Cipollone J, Roskelley CD, Mehl E, Gilks CB (2010) Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases. Int J Gynecol Pathol 29(2):99–107. https://doi.org/10.1097/PGP.0b013e3181bbbcc1 (PMID:20173494) CrossRefPubMedGoogle Scholar
- 43.Hu A, Li H, Zhang L, Ren C, Wang Y, Liu Y, Liu C (2015) Differentiating primary and extragenital metastatic mucinous ovarian tumours: an algorithm combining PAX8 with tumour size and laterality. J Clin Pathol 68(7):522–528. https://doi.org/10.1136/jclinpath-2015-202951 (PMID:25827135) CrossRefPubMedPubMedCentralGoogle Scholar
- 44.Strickland S, Wasserman JK, Giassi A, Djordjevic B, Parra-Herran C (2016) Immunohistochemistry in the diagnosis of mucinous neoplasms involving the ovary: the added value of SATB2 and biomarker discovery through protein expression database mining. Int J Gynecol Pathol 35(3):191–208. https://doi.org/10.1097/PGP.0000000000000238 (PMID:26535987) CrossRefPubMedGoogle Scholar
- 47.Goldberg A, Hand L, DeCotiis D, Rosenblum N, Chan J (2018) Microcystic, elongated, and fragmented pattern invasion in ovarian endometrioid carcinoma: immunohistochemical profile and prognostic implications. Int J Gynecol Pathol 37(1):44–51. https://doi.org/10.1097/PGP.0000000000000384 (PMID:28319570) CrossRefPubMedGoogle Scholar
- 50.Takeda T, Banno K, Okawa R, Yanokura M, Iijima M, Irie-Kunitomi H, Nakamura K, Iida M, Adachi M, Umene K, Nogami Y, Masuda K, Kobayashi Y, Tominaga E, Aoki D (2016) ARID1A gene mutation in ovarian and endometrial cancers (review). Oncol Rep 35(2):607–613. https://doi.org/10.3892/or.2015.4421 (PMID:26572704) CrossRefPubMedGoogle Scholar
- 54.Lim D, Ip PPC, Cheung ANY, Kiyokawa T, Oliva E (2015) Immunohistochemical comparison of ovarian and uterine endometrioid carcinoma, endometrioid carcinoma with clear cell change, and clear cell carcinoma. Am J Surg Pathol 39(8):1061–1069. https://doi.org/10.1097/PAS.0000000000000436 (PMID:25871622) CrossRefPubMedGoogle Scholar
- 56.George EM, Herzog TJ, Neugut AI, Lu YS, Burke WM, Lewin SN, Hershman DL, Wright JD (2013) Carcinosarcoma of the ovary: natural history, patterns of treatment, and outcome. Gynecol Oncol 131(1):42–45. https://doi.org/10.1016/j.ygyno.2013.06.034 (PMID:23838036) CrossRefPubMedPubMedCentralGoogle Scholar
- 60.Rathore R, Sharma S, Arora D (2017) Clinicopathological evaluation of 223 cases of mature cystic teratoma, ovary: 25-year experience in a single tertiary care centre in India. J Clin Diagn Res 11(4):EC11–EC14. https://doi.org/10.7860/JCDR/2017/23909.9612 (PMID:28571142) CrossRefPubMedPubMedCentralGoogle Scholar
- 63.Akakpo PK, Derkyi-Kwarteng L, Gyasi RK, Quayson SE, Naporo S, Anim JT (2017) A pathological and clinical study of 706 primary tumours of the ovary in the largest tertiary hospital in Ghana. BMC Women’s Health 17(1):34. https://doi.org/10.1186/s12905-017-0389-8 (PMID:28415994) CrossRefPubMedPubMedCentralGoogle Scholar